Stocks
Theravance Biopharma, Inc.TBPH
NASDAQHealthcareBiotechnology$13.78-0.79%
Focused on respiratory and inflammatory diseases, the company develops and commercializes small‑molecule medicines and maintains royalty interests in partnered therapies. Its revenue base is largely tied to royalties from global sales of inhaled respiratory treatments developed with partners, alongs...
Market Cap: $698.3M52W Range: $7.90 – $21.03
This page tracks all publicly disclosed congressional trades in Theravance Biopharma, Inc. (TBPH), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 2 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
3
Unique Politicians
2
Buys
2
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-24 | George Whitesides | sell | $15K – $50K |
| 2016-11-07 | MICHAEL T. MCCAUL | buy | $1K – $15K |